Cargando…

Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders

BACKGROUND: Early detection of oral cancer is of critical importance because survival rates markedly improve when oral lesions are identified at an early stage. Aim of the present study is to investigate the expression of ABO (H) antigens in tissue specimens of oral cancer and potentially malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokala, Archana, Paramkusam, Geetha, Tejasvi, M L Avinash, Bangi, Balaji Babu, Nadendla, Lakshmi Kavitha, Devulapalli, Revath Vyas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445960/
https://www.ncbi.nlm.nih.gov/pubmed/32334486
http://dx.doi.org/10.31557/APJCP.2020.21.4.1163
_version_ 1783574086740344832
author Pokala, Archana
Paramkusam, Geetha
Tejasvi, M L Avinash
Bangi, Balaji Babu
Nadendla, Lakshmi Kavitha
Devulapalli, Revath Vyas
author_facet Pokala, Archana
Paramkusam, Geetha
Tejasvi, M L Avinash
Bangi, Balaji Babu
Nadendla, Lakshmi Kavitha
Devulapalli, Revath Vyas
author_sort Pokala, Archana
collection PubMed
description BACKGROUND: Early detection of oral cancer is of critical importance because survival rates markedly improve when oral lesions are identified at an early stage. Aim of the present study is to investigate the expression of ABO (H) antigens in tissue specimens of oral cancer and potentially malignant disorders and to determine the role of ABO (H) antigens in tumour staging. MATERIALS AND METHODS: A prospective study was conducted on 60 cases of oral cancer and potentially malignant diseases. Specific red cell adherence test (SRCA-test) was used for studying A, B and O (H) antigens in tissue specimens and iso-antigenicity of epithelium was graded according to degree of adherence of indicator red blood cells. RESULTS: Among OSMF group, grade II adherence was seen in 53.3% cases, grade III in 33.3% cases, grade IV in 13.3% cases. In leukoplakia group, grade II adherence was seen in 26.7% cases, grade III adherence in 53.3% cases, grade IV adherence in 20% cases. Within the leukoplakia group, cases with dysplasia showed decreased adherence, compared with cases without dysplasia. Oral cancer group, negative adherence was seen in 13.3% cases, grade I adherence in 46.7% cases, grade II in 40% cases. In oral cancer group, antigen reactivity was less in poorly and moderately differentiated carcinoma, compared to well differentiated carcinoma. CONCLUSIONS: Antigen adherence and degree of loss of ABO (H) antigens in tissue specimens can be used for staging of the tumour.
format Online
Article
Text
id pubmed-7445960
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-74459602020-09-02 Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders Pokala, Archana Paramkusam, Geetha Tejasvi, M L Avinash Bangi, Balaji Babu Nadendla, Lakshmi Kavitha Devulapalli, Revath Vyas Asian Pac J Cancer Prev Research Article BACKGROUND: Early detection of oral cancer is of critical importance because survival rates markedly improve when oral lesions are identified at an early stage. Aim of the present study is to investigate the expression of ABO (H) antigens in tissue specimens of oral cancer and potentially malignant disorders and to determine the role of ABO (H) antigens in tumour staging. MATERIALS AND METHODS: A prospective study was conducted on 60 cases of oral cancer and potentially malignant diseases. Specific red cell adherence test (SRCA-test) was used for studying A, B and O (H) antigens in tissue specimens and iso-antigenicity of epithelium was graded according to degree of adherence of indicator red blood cells. RESULTS: Among OSMF group, grade II adherence was seen in 53.3% cases, grade III in 33.3% cases, grade IV in 13.3% cases. In leukoplakia group, grade II adherence was seen in 26.7% cases, grade III adherence in 53.3% cases, grade IV adherence in 20% cases. Within the leukoplakia group, cases with dysplasia showed decreased adherence, compared with cases without dysplasia. Oral cancer group, negative adherence was seen in 13.3% cases, grade I adherence in 46.7% cases, grade II in 40% cases. In oral cancer group, antigen reactivity was less in poorly and moderately differentiated carcinoma, compared to well differentiated carcinoma. CONCLUSIONS: Antigen adherence and degree of loss of ABO (H) antigens in tissue specimens can be used for staging of the tumour. West Asia Organization for Cancer Prevention 2020-04 /pmc/articles/PMC7445960/ /pubmed/32334486 http://dx.doi.org/10.31557/APJCP.2020.21.4.1163 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pokala, Archana
Paramkusam, Geetha
Tejasvi, M L Avinash
Bangi, Balaji Babu
Nadendla, Lakshmi Kavitha
Devulapalli, Revath Vyas
Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders
title Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders
title_full Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders
title_fullStr Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders
title_full_unstemmed Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders
title_short Histo-Blood Group Antigens in Oral Cancer and Potentially Malignant Disorders
title_sort histo-blood group antigens in oral cancer and potentially malignant disorders
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445960/
https://www.ncbi.nlm.nih.gov/pubmed/32334486
http://dx.doi.org/10.31557/APJCP.2020.21.4.1163
work_keys_str_mv AT pokalaarchana histobloodgroupantigensinoralcancerandpotentiallymalignantdisorders
AT paramkusamgeetha histobloodgroupantigensinoralcancerandpotentiallymalignantdisorders
AT tejasvimlavinash histobloodgroupantigensinoralcancerandpotentiallymalignantdisorders
AT bangibalajibabu histobloodgroupantigensinoralcancerandpotentiallymalignantdisorders
AT nadendlalakshmikavitha histobloodgroupantigensinoralcancerandpotentiallymalignantdisorders
AT devulapallirevathvyas histobloodgroupantigensinoralcancerandpotentiallymalignantdisorders